Early use of fondaparinux at therapeutic dosage in COVID-19 infection

Minerva Anestesiol. 2021 Aug;87(8):958-960. doi: 10.23736/S0375-9393.21.15792-X. Epub 2021 May 7.
No abstract available

MeSH terms

  • Anticoagulants / adverse effects
  • COVID-19*
  • Factor Xa Inhibitors
  • Fondaparinux
  • Humans
  • SARS-CoV-2

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Fondaparinux